Healthcare & Life Sciences
Gliapharm
Switzerland
seed
seed
Stage
1
Investors
About
Gliapharm is a Swiss biotechnology company developing treatments for neurological and psychiatric disorders.
Explore Gliapharm's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.